GeneCentric is attending the 2026 ASCO Annual Meeting to be held May 29-June 2, 2026, in Chicago. A poster co-authored with our collaborators at Atrium Health Wake Forest Baptist Comprehensive Cancer Center will be presented highlighting our ongoing work applying biomarkers such as our FGFR gene signature in different clinical contexts of bladder cancer.

Poster Title:
Impact of FGFR3 pathway activation in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy
Abstract #: 4596
Track: Genitourinary Cancer – Kidney and Bladder
Date/time: Sunday, May 31, 2026 | 9:00am-12:00pm CDT
Location: Hall A (Posters & Exhibits)

Reach out to us at meetings@genecentric.com to schedule a 1:1 meeting with our team in Chicago.